Come up with a name for your new list and we'll add to it:
Akebia Therapeutics raised a round of funding on June 05, 2009. Investors include
Global Cardiovascular Innovation Center.
Akebia Therapeutics is focused on delivering innovative therapies to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Akebia's lead product candidate, vadadustat, is an inv…